Provenchère Sophie, Berroeta Clarisse, Reynaud Catherine, Baron Gabriel, Poirier Isabelle, Desmonts Jean-Marie, Iung Bernard, Dehoux Monique, Philip Ivan, Bénessiano Joëlle
Département d'Anesthésie-Réanimation-Chirurgicale, Groupe Hospitalier Bichat-Claude Bernard (AP-HP), Faculté Xavier Bichat (Université Paris 7), France.
Crit Care Med. 2006 Apr;34(4):995-1000. doi: 10.1097/01.CCM.0000206110.94385.C4.
The purpose of the present study was to evaluate the prognostic implications of perioperative B-type natriuretic peptide (BNP) and cardiac troponin I concentrations in patients undergoing cardiopulmonary bypass for cardiac surgery.
Prospective observational study.
Biochemistry laboratory and surgical care unit in a university hospital.
A total of 92 consecutive patients undergoing elective coronary artery (43 patients) or valve surgery (49 patients).
None.
BNP and cardiac troponin I concentrations were measured before surgery (day 0), and at day 1 after surgery. Postoperative cardiac dysfunction was defined as low cardiac output or hemodynamic instability requiring inotropic support for >24 hrs or congestive heart failure until day 5. One-year survival was also evaluated. Univariate and multivariate analyses were performed. An important BNP secretion was systematically observed after cardiac surgery. Independent predictors of cardiac dysfunction were preoperative New York Health Association class and BNP and cardiac troponin I concentrations measured at day 1. Patients with an elevation of both markers have a 12-fold increased risk of postoperative heart failure. The use of both markers in combination predicted better postoperative heart failure than each one separately. Age, low preoperative left ventricular ejection fraction, and elevated BNP at day 1 (>352 pg/mL) were associated with an increased mortality rate at 1 yr. In multivariate analysis, only left ventricular ejection fraction was significantly associated with 1-yr survival.
Postoperative plasma BNP and cardiac troponin I levels are independent predictors of postoperative cardiac dysfunction after cardiac surgery. Simultaneous measurement of BNP and cardiac troponin I improve the risk assessment of postoperative cardiac dysfunction. However, the association between BNP levels and 1-yr outcome was no longer significant after adjustment on left ventricular ejection fraction.
本研究旨在评估心脏手术体外循环患者围手术期B型利钠肽(BNP)和心肌肌钙蛋白I浓度的预后意义。
前瞻性观察研究。
大学医院的生物化学实验室和外科护理单元。
总共92例连续接受择期冠状动脉手术(43例患者)或瓣膜手术(49例患者)的患者。
无。
在手术前(第0天)和术后第1天测量BNP和心肌肌钙蛋白I浓度。术后心脏功能障碍定义为低心输出量或血流动力学不稳定,需要使用血管活性药物支持>24小时或直至第5天出现充血性心力衰竭。还评估了1年生存率。进行单因素和多因素分析。心脏手术后系统性地观察到重要的BNP分泌。心脏功能障碍的独立预测因素是术前纽约心脏协会分级以及术后第1天测量的BNP和心肌肌钙蛋白I浓度。两种标志物均升高的患者术后心力衰竭风险增加12倍。联合使用这两种标志物预测术后心力衰竭的效果优于单独使用每种标志物。年龄、术前左心室射血分数低以及术后第1天BNP升高(>352 pg/mL)与1年死亡率增加相关。在多因素分析中,只有左心室射血分数与1年生存率显著相关。
术后血浆BNP和心肌肌钙蛋白I水平是心脏手术后术后心脏功能障碍的独立预测因素。同时测量BNP和心肌肌钙蛋白I可改善术后心脏功能障碍的风险评估。然而,在调整左心室射血分数后,BNP水平与1年预后之间的关联不再显著。